Self-Hypnosis Training Doesn't Cut Epidural Use

This article originally appeared here.
Share this content:
Self-Hypnosis Training Doesn't Cut Epidural Use
Self-Hypnosis Training Doesn't Cut Epidural Use

(HealthDay News) -- Self-hypnosis training does not reduce women's epidural use during childbirth, according to a study published online May 11 in BJOG: An International Journal of Obstetrics and Gynaecology.

Soo Downe, Ph.D., from the University of Central Lancashire in the United Kingdom, and colleagues assessed the effect of antenatal group self-hypnosis on epidural use during delivery. At 28 to 32 weeks' gestation, 680 women were randomized to usual care or usual care plus brief self-hypnosis training (two 90-minute groups at around 32 and 35 weeks' gestation plus a daily audio self-hypnosis CD).

The researchers found that there was no statistically significant difference in epidural use (27.9 percent in intervention group versus 30.3 percent in usual care; odds ratio [OR], 0.89, 95 percent confidence interval, 0.64 to 1.24). Similarly, there was no significant difference in 27 of 29 pre-specified secondary clinical and psychological outcomes. However, women in the intervention group had lower actual than anticipated levels of fear and anxiety between baseline and two weeks postnatal (anxiety: OR, −0.72; fear: OR, −0.62).

"Allocation to two third-trimester group self-hypnosis training sessions did not significantly reduce intra-partum epidural analgesia use or a range of other clinical and psychological variables," the authors write.

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »